Lund Melanoma Study Group
11 – 20 of 225
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
(
- Contribution to journal › Article
-
Mark
Acral Melanoma Incidence and Survival Trends in 1990–2020: A Nationwide, Population-based Study
(
- Contribution to journal › Article
-
Mark
The Burden of Multiple Basal Cell Carcinomas : A Population-wide Study
(
- Contribution to journal › Article
-
Mark
Interobserver agreement on line-field confocal optical coherence tomography image markers in keratinocyte carcinomas and precursor lesions
(
- Contribution to journal › Article
-
Mark
Melanoma Incidence and Mortality Trends in Sweden
2024) In JAMA Dermatology(
- Contribution to journal › Article
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
(
- Contribution to journal › Article
- 2023
-
Mark
Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
(
- Contribution to journal › Article
-
Mark
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
(
- Contribution to journal › Article
-
Mark
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
(
- Contribution to journal › Article
-
Mark
South Africa and the Surgical Diaspora-A Hub for Surgical Migration and Training
(
- Contribution to journal › Article